BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24240169)

  • 21. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
    Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
    Fagan RJ; Dingwall AK
    Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
    Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
    Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
    Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ
    Cancer Cell; 2019 Feb; 35(2):297-314.e8. PubMed ID: 30753827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
    Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
    Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis.
    Yang W; Ernst P
    Curr Opin Hematol; 2017 Jul; 24(4):322-328. PubMed ID: 28375985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer.
    Xiong W; Deng Z; Tang Y; Deng Z; Li M
    Biochem Biophys Res Commun; 2018 Sep; 504(1):129-136. PubMed ID: 30177394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting KMT2D missense mutations in Kabuki syndrome patients.
    Cocciadiferro D; Augello B; De Nittis P; Zhang J; Mandriani B; Malerba N; Squeo GM; Romano A; Piccinni B; Verri T; Micale L; Pasqualucci L; Merla G
    Hum Mol Genet; 2018 Nov; 27(21):3651-3668. PubMed ID: 30107592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.
    Micale L; Augello B; Maffeo C; Selicorni A; Zucchetti F; Fusco C; De Nittis P; Pellico MT; Mandriani B; Fischetto R; Boccone L; Silengo M; Biamino E; Perria C; Sotgiu S; Serra G; Lapi E; Neri M; Ferlini A; Cavaliere ML; Chiurazzi P; Monica MD; Scarano G; Faravelli F; Ferrari P; Mazzanti L; Pilotta A; Patricelli MG; Bedeschi MF; Benedicenti F; Prontera P; Toschi B; Salviati L; Melis D; Di Battista E; Vancini A; Garavelli L; Zelante L; Merla G
    Hum Mutat; 2014 Jul; 35(7):841-50. PubMed ID: 24633898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4.
    Dhar SS; Lee SH; Kan PY; Voigt P; Ma L; Shi X; Reinberg D; Lee MG
    Genes Dev; 2012 Dec; 26(24):2749-62. PubMed ID: 23249737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
    Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
    Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.
    Shinsky SA; Hu M; Vought VE; Ng SB; Bamshad MJ; Shendure J; Cosgrove MS
    J Mol Biol; 2014 Jun; 426(12):2283-99. PubMed ID: 24680668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule inhibitors of the prostate cancer target KMT2D.
    Yu Q; Liao Z; Liu D; Xie W; Liu Z; Liao G; Wang C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):540-547. PubMed ID: 32988590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
    Carosso GA; Boukas L; Augustin JJ; Nguyen HN; Winer BL; Cannon GH; Robertson JD; Zhang L; Hansen KD; Goff LA; Bjornsson HT
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31465303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration.
    Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668765
    [No Abstract]   [Full Text] [Related]  

  • 37. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
    Li M; Shi M; Xu Y; Qiu J; Lv Q
    Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder.
    Shpargel KB; Quickstad G
    Birth Defects Res; 2023 Dec; 115(20):1885-1898. PubMed ID: 37800171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
    Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
    Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
    Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
    mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.